Visceral Leishmaniasis in the Mediterranean area

Dèlia Reina¹, Hèctor Corominas^{1

2}

Affiliations

¹ Department of Rheumatology, Hospital Moisès Broggi, Barcelona, Catalonia, Spain.
² Rheumatology Division and Lupus Center, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA.

Comment

Dèlia Reina et al. Eur J Rheumatol. 2018 Mar.

. 2018 Mar;5(1):79-80.

doi: 10.5152/eurjrheum.2017.17104. Epub 2017 Nov 2.

Dèlia Reina¹, Hèctor Corominas^{1

2}

¹ Department of Rheumatology, Hospital Moisès Broggi, Barcelona, Catalonia, Spain.
² Rheumatology Division and Lupus Center, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA.

No abstract available

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature.
Trigkidis K, Geladari E, Kokkinakis E, Vallianou N. Trigkidis K, et al. Eur J Rheumatol. 2017 Jun;4(2):139-141. doi: 10.5152/eurjrheum.2017.16066. Epub 2017 Apr 11. Eur J Rheumatol. 2017. PMID: 28638689 Free PMC article.

1. Trigkidis K, Geladari E, Kokkinakis E, Vallianou N. Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature. Eur J Rheumatol. 2017 doi: 10.5152/eurjrheum.2017.16066. doi: 10.5152/eurjrheum.2017.16066. - DOI - DOI - PMC - PubMed
1. Reina D, Cerdà D, Güell E, Martínez Montauti J, Pineda A, Corominas H. Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate. Reumatol Clin. 2016 Aug 11; doi: 10.1016/j.reuma.2016.07.005. doi: 10.1016/j.reuma.2016.07.005. pii: S1699-258X(16)30086-9. - DOI - DOI - PubMed
1. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509. doi: 10.1136/annrheumdis-2013-204573. - DOI - PMC - PubMed
1. Moya P, Salazar J, Arranz MJ, Díaz-Torné C, del Río E, Casademont J, Corominas H, Baiget M. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. Pharmacogenomics. 2016;17:25–29. doi: 10.2217/pgs.15.150. - DOI - PubMed
1. Criswell LA, Saag KG, Sems KM, Welch V, Shea B, Wells G, et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;2 - PMC - PubMed